Clinical Trials
2 trialsNCT07530666 2026-04-15
Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia
Dartsbio Pharmaceuticals Ltd.
Phase 1/2 Not yet recruiting
NCT00933361 2017-08-01
Individual Dose-escalated Bi-daily Subcutaneously (sc) Ghrelin in Cancer Cachexia: a Phase I/II Study
Cantonal Hospital of St. Gallen
Phase 1/2 Completed